Fan KY, Lalani N, Le Vasseur N, Krauze A, Hsu F, Gondara L, Willemsma K, & Nichol AM. (2021). Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy. Journal of Neuro-Oncology, 151(2), 231-231. https://doi.org/10.1007/s11060-020-03657-8

FAN KY, LALANI N, LEVASSEUR N, KRAUZE A, HSU F, GONDARA L, WILLEMSMA K und NICHOL AM, 2021. Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy. Journal of neuro-oncology. 1 Januar 2021. Vol. 151, no. 2, p. 231-231. DOI 10.1007/s11060-020-03657-8.

Fan KY, Lalani N, Le Vasseur N, Krauze A, Hsu F, Gondara L, Willemsma K, und Nichol AM. „Type and Timing of Systemic Therapy Use Predict Overall Survival for Patients With Brain Metastases Treated With Radiation Therapy.“. Journal of Neuro-Oncology, Bd. 151, Nr. 2, Januar 2021, S. 231-, https://doi.org/10.1007/s11060-020-03657-8.

Fan KY/Lalani N/Le Vasseur N/Krauze A/Hsu F/Gondara L u. a.: Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy., Journal of neuro-oncology 2021, 231-231.

Fan KY, Lalani N, Le Vasseur N, Krauze A, Hsu F, Gondara L, Willemsma K und Nichol AM. (2021), „Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy.“, Journal of Neuro-Oncology, Vol. 151 No. 2, S. 231-231.